Specific HRT tablets linked to increased risk of heart disease and blood clots

Certain hormone replacement therapy (HRT) tablets containing both estrogen and progestogen are associated with a higher risk of heart disease and rare but serious blood clots known as venous thromboembolism (VTE) in women around the age of menopause, finds a study from Sweden published by The BMJ today.

Rice360 celebrates expansion of newborn health program in Tanzania

Rice University President Reginald DesRoches joined Rice360 Institute for Global Health Technologies Co-Director Maria Oden and Rice360 supporters on a trip to Africa this summer

July 26, 2024

Why Novartis is changing the name of its research labs

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy. The hub, which is headquartered in Cambridge, Mass.,

September 8, 2023

Responding to Mpox: Global outbreak, research innovations, and therapeutic strategies

In August 2024, the WHO declared Mpox (formerly known as Monkeypox) a global health emergency due to rising Clade I Mpox cases in Africa and

August 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.